跳至主要内容
临床试验/NCT02926846
NCT02926846已完成4 期

Randomized Trial on Intravenous Antibiotics With Adjunctive Lavage for Severe Peritoneal-dialysis Related Peritonitis

Alice Ho Miu Ling Nethersole Hospital1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2014年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
46
试验地点
1
主要终点
Peritoneal dialysate effluent (PDE) white cell count and bacterial culture

研究概览

简要总结

This is a randomized controlled trial to evaluate whether a switch to intravenous antibiotics with adjunctive lavage can improve the outcome of severe peritoneal dialysis related peritonitis.

详细描述

The standard treatment of peritoneal dialysis (PD) related peritonitis is intraperitoneal (IP) antibiotics. In severe cases not responding to the IP antibiotics treatment, timely Tenckhoff catheter removal is needed. There is no known adjunctive measure that can improve the clinical outcome of the patients suffering from severe PD peritonitis.

Based on the past experience in the investigators' center, switching IP to intravenous route of antibiotics administration, together with adjunctive lavage was proposed to improve the clinical outcome of severe PD peritonitis, in particular a possible improved catheter salvage rate. This method will be evaluated in the present clinical trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Prevalent PD patients with age >= 18 years old suffering from PD peritonitis
  • PD effluent white cell count >1090/mm2 on peritonitis day 3
  • Lack of clinical response
  • Informed consent available

排除标准

  • PD peritonitis in association with exit site or tunnel infection
  • Relapsing peritonitis (i.e. peritonitis caused by same organism within 4 weeks after completion of antibiotics therapy)
  • Fungal peritonitis
  • Mycobacterial peritonitis (both tuberculosis and non-tuberculosis species)
  • Clinical suspicion of surgical peritonitis
  • Penicillin- or cephalosporin allergy, that cefazolin and ceftazidime could not be used

研究组 & 干预措施

Lavage arm

Experimental

Intravenous vancomycin & gentamicin with adjunctive lavage

干预措施: Intravenous vancomycin & gentamicin with adjunctive lavage (Drug)

Standard treatment arm

Active Comparator

Intraperitoneal vancomycin & gentamicin

干预措施: Intraperitoneal vancomycin & gentamicin (Drug)

结局指标

主要结局

Peritoneal dialysate effluent (PDE) white cell count and bacterial culture

时间窗: PDE is monitored every 48 hours, until white cell count <100/mm3 and bacterial culture is negative; assessed up to 3 weeks

Number of participants requiring Tenckhoff catheter removal

时间窗: Tenckhoff catheter removal is arranged when there is no clinical response after 5 days of treatment

次要结局

  • Number of participants developing relapsing peritonitis(All participants are observed for any peritonitis within 4 weeks of completion of antibiotics treatment)
  • Number of participants requiring hospitalization(All participants are observed for any hospitalization within 12 weeks of completion of antibiotics treatment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Steve Siu-Man Wong

Associate Consultant

Alice Ho Miu Ling Nethersole Hospital

研究点 (1)

Loading locations...

相似试验